Biotechnology | HIV | Therapeutics | Vaccine
Phase III results for first HIV/AIDS (Aidsvax) vaccine reported
On February 24 2003, VaxGen announced that AIDSVAX B/B did not prove effective in the trials conducted in…
Biotechnology | Disease | FDA | Medicine | Therapeutics
Long-term efficacy and safety of etanercept was found in children with polyarticular-course juvenile rheumatoid arthritis
On Jan. 10, 2003, long-term efficacy and safety of etanercept (Enbrel) was found in children with polyarticular-course juvenile…
China granted the world’s first regulatory approval of a gene therapy product
In 2003, China granted the world’s first regulatory approval of a gene therapy product, Gendicine (Shenzhen SiBiono GenTech),…
Two randomized controlled trials showed that taking aspirin daily for as little as three years reduces the development of colorectal polyps
In 2003, two randomized controlled trials showed that taking aspirin daily for as little as three years reduces…
The Institute for Collaborative Biotechnologies was founded
In 2003, The Institute for Collaborative Biotechnologies (ICB) was founded as an Army-sponsored University Affiliated Research Center (UARC)….
The Roskamp Institute was founded
In 2003, the Roskamp Institute, located in Sarasota, was founded by Robert Roskamp a philanthropist and Sarasota-based developer…
The Broad Institute was founded with $100 million gift from Eli and Edythe Broad
In 2003, The Broad Institute was announced with a $100 million gift from Eli and Edythe Broad. Discussions…
Institute for Research in Immunology and Cancer created at the University of Montreal to discover more effective cancer therapies
In 2003, the Institute for Research in Immunology and Cancer (IRIC) was created at the University of Montreal…
Biotechnology | Diagnostics | Disease | Medical Device | Medicine | Non-Profit Research | Therapeutics
The Medical University of South Carolina and Clemson University established joint Bioengineering Program
In 2003, the Medical University of South Carolina and Clemson University established a joint Bioengineering Program. Located on…
William Hagopian at the Pacific Northwest Research Institute began Phase I of the hOKT3 study
In 2003, Dr. William Hagopian at the Pacific Northwest Research Institute began Phase I of the hOKT3 study….
Biotechnology | Diagnostics | Disease | NIH | Oncology | Radiology | Therapeutics
NCI clinical trial showed reduced intervals between chemotherapy improved survival in women whose breast cancer had spread to lymph nodes
On Dec. 12, 2002, the National Cancer Institute (NCI) announced that a clinical trial had shown that reducing…
The mouse genome was first sequenced and published
On Dec. 5, 2002, the international Mouse Genome Sequencing Consortium announced the publication of a high-quality draft sequence…
Sidney Kimmel gave $150 million to Hopkins for cancer research and patient
On Dec. 1, 202, Sidney Kimmel, founder and chairman of Jones Apparel Group, donated $150 million for cancer…
International consortium launched genetic variation mapping project
On Oct. 29, 2002, an international research consortium launched a $100 million public-private effort to create the next…
OHSU broke ground on new biomedical research building
On Oct. 10, 2002, the Oregon Opportunity arrived as Oregon Health & Science University (OHSU) broke ground for…
The Public Health Security and Bioterrorism Preparedness and Response Act (PL 107-188) was signed
On Sept. 10, 2002, the Public Health Security and Bioterrorism Preparedness and Response Act (P.L. 107-188) was passed…
The Alberta Innovates Centre for Carbohydrate Science began operation
In Sept. 2002, the Alberta Innovates Centre for Carbohydrate Science (now Alberta Glycomics Centre), began operation with a…
Biotechnology | FDA | Oncology | Therapeutics
FDA approved Amgen’s aranesp for anemia associated with chemotherapy
On Jul. 22, 2002, Amgen announced that the U.S. Food and Drug Administration (FDA) had approved Aranesp (darbepoetin…
NCI funded trial showed postmenopausal women who used estrogen replacement therapy were at higher risk of developing ovarian cancer
On Jul. 17, 2002, A National Cancer Institute funded trial showed that postmenopausal women who used estrogen replacement…
Immunex Corp. was acquired by Amgen
On Jul. 16, 2002, Amgen completed it’s acquisition of Immunex Corporation for $16 billion in stock and net…
Biotechnology | Diagnostics | Disease | Life Science History | NIH | Non-Profit Research | Oncology | Therapeutics | Veterinary
The UC Davis Cancer Center received NCI designation
On Jul. 2, 2002, the University of California, Davis Comprehensive Cancer Center announced it had received National Cancer…
University of Minnesota researchers Povide Evidence That Adults Stem Cells Differentiate Like Embryonic Stem Cells
On Jun. 24, 2002, researchers at the University of Minnesota Stem Cell Institute (SCI) announced they had found…
Biotechnology | Diagnostics | NIH | Oncology | Therapeutics
NCI scientists identified adult patients with non-Hodgkin’s lymphoma likely to be cured by chemotherapy
On Jun. 19, 2002, National Cancer Institute (NCI) scientists used microarray technology to determine the patterns of genes…
Biotechnology | Diagnostics | FDA | Infectious Disease | Medicine | NIH | Plague | Radiology | Therapeutics | U.S. Congress
President Bush signed the Public Health Security and Bioterrorism Preparedness and Response Act into law
On Jun. 12, 2002, President George W. Bush signed the Public Health Security and Bioterrorism Preparedness and Response…
The Salt River Pima-Maricopa Indian Community pledged $5 million to the Translational Genomics Research Institute
On Jun. 8, 2002, the Salt River Pima-Maricopa Indian Community pledged $5 million to the Translational Genomics Research…
The Translational Genomics Research Institute (TGen) was founded
In Jun. 2002, the Translational Genomics Research Institute (TGen), a non-profit 501(c)(3) organization focused on developing earlier diagnostics…
NCI researchers reported that the molecularly targeted drug bevacizumab slowed tumor growth in patients with metastatic renal cell carcinoma
On May 19, 2002, researchers from the National Cancer Institute reported that the molecularly targeted drug bevacizumab slowed…
Biotechnology | CDC | NIH | Oncology | Therapeutics | U.S. Congress
The Hematologic Cancer Research Investment and Education Act Signed into Law
On May 14, 2002, President George W. Bush signed the Hematologic Cancer Research Investment and Education Act of…
The International Genomics Consortium selected Phoenix for its headquarters
On May 14, 2002, the International Genomics Consortium (IGC) selected Phoenix for its headquarters. The mission of the…
Quinton Cardiology launched its IPO
On May 7, 2002, Quinton Cardiology Systems held its Initial Public Offering raising $28 million. The Bothell, Washington…